GlassScriptBrevera Breast Biopsy System
Payments companies reported to CMS as associated with Brevera Breast Biopsy System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Brevera Breast Biopsy System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Brevera Breast Biopsy System
These are the largest totals companies reported as associated with Brevera Breast Biopsy System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stacy Smith-Foley | Little Rock, AR | Diagnostic Radiology | $11,161.32 |
| Tchaiko Parris | Green Bay, WI | Diagnostic Radiology | $9,733.51 |
| Jason Katzen | Washington, DC | Diagnostic Radiology | $9,650.00 |
| Susan Shamburger | Jackson, MS | Diagnostic Radiology | $2,508.19 |
| Colleen Madden | Muncie, IN | Diagnostic Radiology | $2,019.69 |
| Susan Boolbol | Poughkeepsie, NY | Surgery | $1,903.54 |
| Linda Greer | Phoenix, AZ | Diagnostic Radiology | $1,633.52 |
| Laurie Fajardo | Saint Louis, MO | Diagnostic Radiology | $1,500.00 |
| Michael Morris | Scottsdale, AZ | Diagnostic Radiology | $1,200.00 |
| Jessica Leung | Houston, TX | Diagnostic Radiology | $450.00 |
Prescribed Brevera Breast Biopsy System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.